Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Aug 16.
Published in final edited form as: Neuropharmacology. 2022 Jul 13;216:109188. doi: 10.1016/j.neuropharm.2022.109188

Retraction notice to “Chronic fluoxetine treatment in vivo enhances excitatory synaptic transmission in the hippocampus” [Neuropharmacology, 150 (15th May 2019) 38–45]

Adam M Van Dyke a,b,c, T Chase Francis a,b, Haiwen Chen a,b,c,d, Aileen M Bailey e, Scott M Thompson a,*
PMCID: PMC9377285  NIHMSID: NIHMS1828909  PMID: 35842328

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).

This article has been retracted at the request of the Authors.

After publication, Scott M. Thompson found significant concerns about the data and duly notified The University of Maryland. The University of Maryland conducted an internal investigation which confirmed that the article was compromised. Namely in Figure 2B, the Investigation Committee determined that the western blots used to create the figure were not the ones used for the quantification and concluded that the figure was falsified to fit the hypothesis. In Figure 2C and D, the Investigation Committee determined that the densitometry data (pCaMKII, pS831, CamKII and GluA1) used to create the histogram were falsified to fit the hypothesis.

Footnotes

RESOURCES